Top Health Care Stocks
Health care stocks fell Monday, with the NYSE Health Care Index falling about 0.6% while shares of health care companies in the S&P 500 were down about 0.1% as a group.
In company news, Aptose Bioscience ( APTO ) rebounded Monday after a positive Barron's article said more clarity for the drugmaker's investors will emerge once questions over its manufacturing processes and a patent dispute are cleared up.
Aptose shares slid 53% to a record low on Friday after it said he Food and Drug Administration placed on a hold on Phase Ib testing of its APTO-253 drug candidate in patients with relapsed/refractory hematologic malignancies, following a voluntary suspension of patient dosing by the company.
The company said the suspension resulted from an accelerated review of its manufacturing processes and procedures after reports of operational difficulty with one of its intervenous drug infusion pumps at a trial site.
APTO shares were up over 22% today at $3.07 each, climbing as high as $3.00 a share during prior trade.
In other sector news,
(+) CANF, Expands likely patient population for its CF102 drug candidate, adding patients with non-alcoholic steatohepatitis to its current Phase II testing in patients with hepatocellular carcinoma, the most common form of liver cancer.
(-) APDN, Slates $7.73 mln private placement of of 2.5 mln shares at $3.49 each, an 18.3% discount to Friday's closing price. Also sells warrants to purchase 1.25 mln shares exercisable at $4.30 per share for 1 cent per warrant, or $12.500 overall.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.